Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07119398

Oxytocin/Foley vs. Oxytocin for Induction in Patients With PPROM

Combination Oxytocin/Foley Versus Oxytocin Alone for Induction of Labor in Patients With Preterm Prelabor Rupture of Membranes

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Eastern Virginia Medical School · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Data on the optimal mode of labor induction after preterm prelabor rupture of membranes (PPROM) is lacking. Studies have shown no difference between oxytocin and misoprostol use for labor induction in this cohort (1). The preponderance of evidence from term pregnancies suggests that Foley catheter coupled with oxytocin is better than oxytocin alone, with a higher rate of delivery within 24 hours when a Foley catheter followed by oxytocin is compared to oxytocin alone. However, the use of a Foley catheter has not been evaluated in prospective studies on patients with PPROM.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTOxytocin plus Foley CatheterIntravenous oxytocin and a transcervical Foley catheter
DRUGOxytocinIntravenous oxytocin

Timeline

Start date
2025-07-14
Primary completion
2026-07-30
Completion
2026-12-30
First posted
2025-08-13
Last updated
2025-08-13

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07119398. Inclusion in this directory is not an endorsement.